Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−22 JPY
−1.22 B JPY
682.46 M JPY
60.12 M
About CHIOME BIOSCIENCE INC
Sector
Industry
Headquarters
Tokyo
Website
Founded
2005
ISIN
JP3205350006
FIGI
BBG00283XKL6
Chiome Bioscience, Inc. engages in the development and sale of antibody drugs through the Autonomous Diversifying Library (ADLib) system. Its operations are carried out through the Drug Discovery and Drug Discovery Support business segments. The Drug Discovery segment develops antibody drug development in disease areas where unmet needs are high, out-license patents and other licenses related to the resulting antibody to pharmaceutical companies. The Drug Discovery Support segment handles antibody production using antibody production technologies to support drug discovery research conducted by research institutes such as pharmaceutical companies, diagnostic drug companies, and universities. The company was founded by Kunihiro Ohta on February 8, 2005 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4583 is 259 JPY — it has decreased by −1.96% in the past 24 hours. Watch CHIOME BIOSCIENCE INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange CHIOME BIOSCIENCE INC stocks are traded under the ticker 4583.
4583 stock has fallen by −9.42% compared to the previous week, the month change is a 5.04% rise, over the last year CHIOME BIOSCIENCE INC has showed a 110.57% increase.
4583 reached its all-time high on Jan 29, 2013 with the price of 5,320 JPY, and its all-time low was 75 JPY and was reached on Aug 5, 2024. View more price dynamics on 4583 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4583 stock is 6.50% volatile and has beta coefficient of 0.89. Track CHIOME BIOSCIENCE INC stock price on the chart and check out the list of the most volatile stocks — is CHIOME BIOSCIENCE INC there?
Today CHIOME BIOSCIENCE INC has the market capitalization of 16.27 B, it has decreased by −9.93% over the last week.
Yes, you can track CHIOME BIOSCIENCE INC financials in yearly and quarterly reports right on TradingView.
CHIOME BIOSCIENCE INC is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
4583 net income for the last quarter is −351.54 M JPY, while the quarter before that showed −259.93 M JPY of net income which accounts for −35.24% change. Track more CHIOME BIOSCIENCE INC financial stats to get the full picture.
No, 4583 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 51.00 employees. See our rating of the largest employees — is CHIOME BIOSCIENCE INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHIOME BIOSCIENCE INC EBITDA is −1.22 B JPY, and current EBITDA margin is −176.41%. See more stats in CHIOME BIOSCIENCE INC financial statements.
Like other stocks, 4583 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHIOME BIOSCIENCE INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHIOME BIOSCIENCE INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHIOME BIOSCIENCE INC stock shows the buy signal. See more of CHIOME BIOSCIENCE INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.